BAM66435 Vandetanib Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively. Quantity Price 25 mg 65.00 100 mg 220.00 250 mg 475.00                     C22H24BrFN4O2 443913-73-3 98+% MFCD07772346

BAM66435 Zactima Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively. Quantity Price 25 mg 65.00 100 mg 220.00 250 mg 475.00                     C22H24BrFN4O2 443913-73-3 98+% MFCD07772346

BAM66435 ZD6474 Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively. Quantity Price 25 mg 65.00 100 mg 220.00 250 mg 475.00                     C22H24BrFN4O2 443913-73-3 98+% MFCD07772346

BAM66466 Saracatinib (AZD0530) Saracatinib (AZD0530) is a highly selective, orally available, dual-specific Src/Abl kinase inhibitor with IC50 of 2.7 and 30 nM for c-Src and Abl kinase, respectively. Quantity Price 10 mg 60.00 50 mg 188.00 100 mg 336.00 200 mg $495.00                 C27H32ClN5O5   98+% MFCD09832698

BAM66469 PH-797804 PH-797804 is a highly selective, potent, and ATP-competitive p38 MAP kinase inhibitor with an IC50 of 2.3 nM. Quantity Price 5 mg 170.00 10 mg 320.00 50 mg 970.00 200 mg 2470.00                 C22H19BrF2N2O3   98+% MFCD18251426

[1/6]